These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 31317205)

  • 21. Reg4+ deep crypt secretory cells function as epithelial niche for Lgr5+ stem cells in colon.
    Sasaki N; Sachs N; Wiebrands K; Ellenbroek SI; Fumagalli A; Lyubimova A; Begthel H; van den Born M; van Es JH; Karthaus WR; Li VS; López-Iglesias C; Peters PJ; van Rheenen J; van Oudenaarden A; Clevers H
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5399-407. PubMed ID: 27573849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer cell metabolism connects epigenetic modifications to transcriptional regulation.
    Morrison AJ
    FEBS J; 2022 Mar; 289(5):1302-1314. PubMed ID: 34036737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN, stem cells, and cancer stem cells.
    Hill R; Wu H
    J Biol Chem; 2009 May; 284(18):11755-9. PubMed ID: 19117948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states.
    Song H; Weinstein HNW; Allegakoen P; Wadsworth MH; Xie J; Yang H; Castro EA; Lu KL; Stohr BA; Feng FY; Carroll PR; Wang B; Cooperberg MR; Shalek AK; Huang FW
    Nat Commun; 2022 Jan; 13(1):141. PubMed ID: 35013146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncohistones: a roadmap to stalled development.
    Deshmukh S; Ptack A; Krug B; Jabado N
    FEBS J; 2022 Mar; 289(5):1315-1328. PubMed ID: 33969633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling Gastrointestinal Diseases Using Organoids to Understand Healing and Regenerative Processes.
    Ollivier A; Mahe MM; Guasch G
    Cells; 2021 May; 10(6):. PubMed ID: 34072095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a protocol for maintaining viability while shipping organoid-derived retinal tissue.
    Singh RK; Winkler P; Binette F; Glickman RD; Seiler M; Petersen-Jones SM; Nasonkin IO
    J Tissue Eng Regen Med; 2020 Feb; 14(2):388-394. PubMed ID: 31908157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer.
    Norkin M; Ordóñez-Morán P; Huelsken J
    Cell Rep; 2021 Apr; 35(3):109026. PubMed ID: 33882314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organoids: Avatars for Personalized Medicine.
    Clevers HC
    Keio J Med; 2019; 68(4):95. PubMed ID: 31875622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initiation of Cancer: The Journey From Mutations in Somatic Cells to Epigenetic Changes in Tissue-resident VSELs.
    Bhartiya D; Raouf S; Pansare K; Tripathi A; Tripathi A
    Stem Cell Rev Rep; 2024 May; 20(4):857-880. PubMed ID: 38457060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brief summary of the current protocols for generating intestinal organoids.
    Miura S; Suzuki A
    Dev Growth Differ; 2018 Aug; 60(6):387-392. PubMed ID: 30039581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
    Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
    J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic alterations involved in cancer stem cell reprogramming.
    Muñoz P; Iliou MS; Esteller M
    Mol Oncol; 2012 Dec; 6(6):620-36. PubMed ID: 23141800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early epigenetic cancer decisions.
    Martín-Lorenzo A; Gonzalez-Herrero I; Rodríguez-Hernández G; García-Ramírez I; Vicente-Dueñas C; Sánchez-García I
    Biol Chem; 2014 Nov; 395(11):1315-20. PubMed ID: 25205718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stem cell niche in tissue homeostasis, aging and cancer.
    Singh SR
    Curr Med Chem; 2012; 19(35):5965-74. PubMed ID: 22963571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mini-gut organoids: reconstitution of the stem cell niche.
    Date S; Sato T
    Annu Rev Cell Dev Biol; 2015; 31():269-89. PubMed ID: 26436704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells.
    Shah M; Allegrucci C
    Subcell Biochem; 2013; 61():545-65. PubMed ID: 23150267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal stem cells: an update on their potential in regenerative medicine.
    Sun X; Fu X; Han W; Zhao M; Chalmers L
    Expert Opin Biol Ther; 2013 Jun; 13(6):901-10. PubMed ID: 23517553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem cells: recent developments and future prospects.
    Singh SR
    Cancer Lett; 2013 Sep; 338(1):1-2. PubMed ID: 23583678
    [No Abstract]   [Full Text] [Related]  

  • 40. Human organoids in basic research and clinical applications.
    Tang XY; Wu S; Wang D; Chu C; Hong Y; Tao M; Hu H; Xu M; Guo X; Liu Y
    Signal Transduct Target Ther; 2022 May; 7(1):168. PubMed ID: 35610212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.